2014
DOI: 10.1007/s11172-014-0585-8
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of an ion-pair HPLC method for determination of perchlozone in blood plasma

Abstract: A procedure involving ion pair HPLC combined with UV detection was developed for determination of the innovative antituberculosis drug perchlozone in human blood plasma and validated in terms of selectivity, calibration curve, accuracy, precision, sensitivity, and stability. The procedure enables determination of the perchlozone concentration in the blood plasmas of patients taking other antituberculosis medication and can be used for both pharmacokinetic investigations and therapeutic monitoring.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(1 reference statement)
0
1
0
Order By: Relevance
“…According to [21] specificity is the ability of the procedure to detect analyte in the presence of components that can be contained in the sample. The procedure specificity was determined using the technique described in [22]. Six samples of pure (containing no analyte) urine and samples of urine with added meldonium solution at precisely known concentration were studied in parallel.…”
Section: Resultsmentioning
confidence: 99%
“…According to [21] specificity is the ability of the procedure to detect analyte in the presence of components that can be contained in the sample. The procedure specificity was determined using the technique described in [22]. Six samples of pure (containing no analyte) urine and samples of urine with added meldonium solution at precisely known concentration were studied in parallel.…”
Section: Resultsmentioning
confidence: 99%